Isodiol International Inc.
Isodiol International Inc. ("Isodiol"), focused on the nutritional health benefits derived from hemp, is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.
Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Isodiol has received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and aggressively continue international expansion into Latin America, Asia, and Europe.
Isodiol International Inc. (ISOL)
Communiqués de presse
le 10 decembre/December 2020
Effective immediately, Isodiol International Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission and the British Columbia Securities Commission.
For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca